InvestSMART

Cochlear Limited (ASX: COH) - Announcements

- Current share price for COH : $150.720

ASX company news and announcements for Cochlear Limited (COH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cochlear Limited (COH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cochlear Limited (COH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cochlear Limited (COH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9,857 Appendix 4G 15 Aug 2024 7:31AM $337.750 $150.720 fallen by 55.38%
$9,857 2024 Tax Contribution Report 15 Aug 2024 7:30AM $337.750 $150.720 fallen by 55.38%
$9,857 FY24 Result - Presentation 15 Aug 2024 7:30AM $337.750 $150.720 fallen by 55.38%
$9,857 FY24 Result - ASX & Media Release 15 Aug 2024 7:30AM $337.750 $150.720 fallen by 55.38%
$9,857 Dividend/Distribution - COH 15 Aug 2024 7:30AM $337.750 $150.720 fallen by 55.38%
$9,857 Annual Report (incl Sustainability reporting) 15 Aug 2024 7:30AM $337.750 $150.720 fallen by 55.38%
$9,857 Appendix 4E 15 Aug 2024 7:30AM $337.750 $150.720 fallen by 55.38%
$9,857 Appointment of Caroline Clarke to the Cochlear Board 30 Jul 2024 8:37AM $342.180 $150.720 fallen by 55.95%
$9,857 Cochlear announces changes to the executive team 26 Jul 2024 10:41AM $340.550 $150.720 fallen by 55.74%
$9,857 Application for quotation of securities - COH 25 Jul 2024 10:55AM $339.705 $150.720 fallen by 55.63%
$9,857 COH Notice of FY24 result analyst and media briefing 10 Jul 2024 9:34AM $319.770 $150.720 fallen by 52.87%
$9,857 Notification of cessation of securities - COH 5 Jul 2024 10:17AM n/a $150.720 n/a
$9,857 Notification regarding unquoted securities - COH 5 Jul 2024 10:14AM n/a $150.720 n/a
$9,857 Notification regarding unquoted securities - COH 5 Jul 2024 10:08AM n/a $150.720 n/a
$9,857 Change of registry address 23 May 2024 5:34PM $322.030 $150.720 fallen by 53.20%
$9,857 Cochlear acquires Demant cochlear implant business 21 May 2024 4:13PM $318.430 $150.720 fallen by 52.67%
$9,857 Change in substantial holding 20 May 2024 6:53PM $319.710 $150.720 fallen by 52.86%
$9,857 Application for quotation of securities - COH 30 Apr 2024 9:58AM $323.830 $150.720 fallen by 53.46%
$9,857 Appointments and retirement of Company Secretary 22 Apr 2024 9:21AM $315.650 $150.720 fallen by 52.25%
$9,857 Notification of cessation of securities - COH 5 Apr 2024 9:36AM $333.590 $150.720 fallen by 54.82%
$9,857 AXX: ACCC will not oppose revised Cochlear, Oticon transacti 4 Apr 2024 9:08AM $329.930 $150.720 fallen by 54.32%
$9,857 Appendix 3Z - Yasmin Allen 2 Apr 2024 9:13AM $337.520 $150.720 fallen by 55.34%
$9,857 Update - Dividend/Distribution - COH 2 Apr 2024 9:09AM $337.520 $150.720 fallen by 55.34%
$9,857 Resignation of Director - Yasmin Allen 25 Mar 2024 10:00AM $334.020 $150.720 fallen by 54.88%
$9,857 Appendix 3Y - Diggory Howitt 15 Mar 2024 9:48AM $336.520 $150.720 fallen by 55.21%

226 - 250 of 947 results

Page 10 of 38

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.